GeoVax Labs, Inc.
GOVX$57M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaSMYRNA
Drugs in Pipeline
3
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Dec 31, 2026
42wMarket Overview
Stock performance and key metrics
GOVX News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1
COVID-19 Infection
COVID-19 Vaccine
COVID-19 Infection
Ad/PNP
Recurrent Head and Neck Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Synthetic MVA-based SARS-CoV-2 Vaccine COH04S1 | Phase 2 | COVID-19 Infection | - | - |
COVID-19 Vaccine | Phase 2 | COVID-19 Infection | - | - |
Ad/PNP | Phase 2 | Recurrent Head and Neck Cancer | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply